Study the effects of high-volume hemofiltration and fluid resuscitation on removing blood lactic acid and pro-inflammatory cytokines in patients with refractory septic shock

Chinese Critical Care Medicine

Volumn 21, Issue 7, 2009, Pages 421-424

  Wang, Chun Ting ^a   Ren, Hong Sheng ^a   Jiang, Jin Jiao ^a   Zhang, Ji Cheng ^a   Meng, Mei ^a   Yu, Jie Bin ^a   Chu, Yu Feng ^a   Ding, Min ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Artery lactate; Fluid resuscitation; High volume hemofiltration; Inflammatory cytokine; Septic shock

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 6; LACTIC ACID; PROCALCITONIN;

ADULT; APACHE; ARTICLE; CLINICAL ASSESSMENT; CRITICALLY ILL PATIENT; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUID RESUSCITATION; HEMOFILTRATION; HUMAN; INFLAMMATION; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; SCORING SYSTEM; SEPTIC SHOCK; TREATMENT OUTCOME;

ADULT; AGED; APACHE; CYTOKINES; FEMALE; HEMOFILTRATION; HUMANS; LACTIC ACID; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PROGNOSIS; RESUSCITATION; SHOCK, SEPTIC; YOUNG ADULT;

EID: 69249198106     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-0603.2009.07.012     Document Type: Article

References (17)

1. Brun-Buisson C. ICU-acquired infections and sepsis: more of a deadly duo. Intensive Care Med, 2008,34(5):793-795.
2. Rhodes A, Bennett ED. Early goal-directed therapy, an evidence-based review. Cirt Care Med, 2004,32(11 Suppl): S448-450.
3. Ratanarat R, Brendolan A, Ricci Z, et al. Pulse high-volume hemofiltration in critically ill patients: a new approach for patients with septic shock. Semin Dial, 2006,19(1):69-74.
4. Quintard H, Rapy E, Massias L, et al. The pharmacokinetic profile voriconazole during continuous high-volume venovenous hemofiltration in a critically ill patient. Ther Drug Monit, 2008,30(1),117-119. (Pubitemid 351161110)
5. Ho KM. Combining sequential organ failure assessment (SOFA) score with acute physiology and chronic health evaluation (APACHE) I score to predict hospital mortality of critically ill patients. Anaesth Intensive Care, 2007,35(4):515-521.
6. Routsi C, Pratikaki M, Sotiropoulou C et al. Application of the sequential organ failure assessment (SOFA) score to bacteremic ICU patients. Infection, 2007,35(4):240-244. (Pubitemid 47222279)
7. Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med, 2004,32(3):858-873. (Pubitemid 38344143)
8. Kocabas E, Sarikcioqlu A, Aksaray N, et al. Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-alpha in the diagnosis of neonatal sepsis. Turk J Pediatr, 2007,49(1):7-20. (Pubitemid 46585449)
9. Dimopoulou I, Orfanos S, Kotanidou A, et al. Plasma pro-and anti-inflammatory cytokine levels and outcome prediction in unselected critically ill patients. Cytokine, 2008,41(3):263-267.
10. Nguyen HB, Rivers EP, Knoblich BP, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock.Crit Care Med, 2004,32(8):1637-1642.
11. Ghani RA, Zainudin S, Ctkong N, et al. Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous venovenous haemofiltration. Nephrology (Carlton), 2006,11(5):386-393. (Pubitemid 44470085)
12. Quintard H, Rapy E, Massias L, et al. The pharmacokinetic profile of voriconazole during continuous high-volume venovenous hemofiltration in a critically ill patient. Ther Drug Monit, 2008,30(1):117-119. (Pubitemid 351161110)